456 results on '"Straten, Per Thor"'
Search Results
2. Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
3. Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy
4. 1318 Characterization of T cell specificity and exercise-induced dynamics of soluble immunological markers before and after high-intensity aerobic exercise (inhale)
5. 1133 Characterization of CD4+ T cell responses against Rho C, a metastasis associated tumor antigen
6. 1083 Functional impact of adrenergic signaling on T and NK cells: where exercise meets cancer
7. 701 Aiming high in HI-AIM; a clinical testing of exercise in cancer
8. 1147-F Human endogenous retrovirus-K proteins form VLPs with dense envelope incorporation – explaining HERV-K immunogenicity in patients and yielding a tool for breaking tolerance to HERV envelope proteins
9. Nucleotide metabolism in the regulation of tumor microenvironment and immune cell function
10. Activation of Preexisting T Cell Clones by Targeted Interleukin 2 Therapy
11. Supplementary Methods from Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2
12. Data from Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2
13. Collagen density regulates the activity of tumor-infiltrating T cells
14. Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
15. Immune Risk Phenotypes and Associated Parameters in Very Old Humans: A Review of Findings in the Swedish NONA Immune Longitudinal Study
16. Extended T-Cell Epitope Landscape in Merkel Cell Polyomavirus Large T and Small T Oncoproteins Identified Uniquely in Patients with Cancer
17. Modeling Metastatic Colonization in a Decellularized Organ Scaffold-Based Perfusion Bioreactor
18. First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
19. Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
20. Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor (Adv. Healthcare Mater. 1/2022)
21. Extended T-Cell Epitope Landscape in Merkel Cell Polyomavirus Large T and Small T Oncoproteins Identified Uniquely in Patients with Cancer
22. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer
23. Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor
24. Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
25. Small molecule inhibitors of mertk and flt3 induce cell cycle arrest in human cd8+ t cells
26. Tam receptor inhibition–implications for cancer and the immune system
27. Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)
28. Tumor-associated antigens characterized in a conceptual framework of biology, microenvironment, and therapy
29. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers
30. Identification of heme oxygenase-1--specific regulatory [CD8.sup.+] T cells in cancer patients
31. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides
32. Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes
33. Regulators of apoptosis: suitable targets for immune therapy of cancer
34. 764 Expansion with IL-15 increases cytotoxicity of Vγ9Vδ2 T cells and is associated with higher levels of cytotoxic molecules and T-bet
35. Aberrant p27Kip1 promoter methylation in malignant melanoma
36. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma
37. Inflammation induced PD-L1-specific T cells
38. Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin
39. Cancer immunity and autoimmunity; two sides of the same coin (?): 22
40. T-cell recognition of large T and small T antigen in Merkel cell polyomavirus-associated cancer
41. Reactivity of naive CD4+CD25− T cells against gut microflora in healthy mice
42. Analysis of T cell receptor αβ variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions
43. Inflammation induced PD-L1-specific T cells
44. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome
45. T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
46. Collagen density regulates the activity of tumor-infiltrating T cells
47. MERTK Acts as a costimulatory receptor on human cd8 t cells
48. Aggregation of Antigen-Specific T Cells at the Inoculation Site of Mature Dendritic Cells
49. Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma
50. Peptide-MHC class 1 tetramers can fail to detect relevant functional T cell clonotypes and underestimate antigen-reactive T cell populations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.